MNMD
Definium Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · CA
$20.69
+0.44%Institutional positioning
13F filings over the trailing two quarters
New 4Increased 1Reduced 0Sold out 8
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BFC Planning, Inc. | Increased | 26,312 | Oct 29, 2026 |
| BFC Planning, Inc. | New Position | 51 | Oct 29, 2026 |
| BFC Planning, Inc. | New Position | 51 | Oct 29, 2026 |
| BFC Planning, Inc. | Unchanged | 51 | Oct 29, 2026 |
| BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC. | Unchanged | 33 | Oct 30, 2026 |
| BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC. | Unchanged | 33 | Oct 30, 2026 |
| BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC. | Unchanged | 33 | Oct 30, 2026 |
| BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC. | New Position | 33 | Oct 30, 2026 |
| BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC. | Unchanged | 33 | Oct 30, 2026 |
| BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC. | Unchanged | 33 | Oct 30, 2026 |
| Bullock Wealth Management Group | New Position | 25 | Oct 30, 2026 |
| BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC. | Sold Out | 0 | Oct 30, 2026 |
| RATHBONES GROUP PLC | Sold Out | 0 | Jun 9, 2026 |
| MORGAN STANLEY | Sold Out | 0 | May 27, 2026 |
| STRATEGIC WEALTH PARTNERS, LTD. | Sold Out | 0 | May 12, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings